retatrutide investigational drug triple hormone receptor agonist Medscape | Retatrutide, Eli Lilly's first-in-class agonist, delivered meaningful weight loss at 80 weeks in all doses in the ADA 2026: Retatrutide Revolution

Your doctor may recommend the highest dose of up to 2.4 mg per week, but this will come as a gradual increase over four to five months

[14] [15] The MHRA has issued warnings about the risks of purchasing medicines from unregulated online sources

Low testosterone replacement: Supports testosterone levels in men with deficiency, contributing to energy, body composition, and performance

Gilbert, Rosenthal, March 2024

the body appears to drift back toward its prior set point, but exactly how and why isn't fully nailed down

Now, the latest studies from healthcare and science professionals are exploring their potential beyond weight loss support alone